LIVER CELL CARCINOMA
Clinical trials for LIVER CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LIVER CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LIVER CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at childhood cancers
Disease control Recruiting nowThis early-stage trial tests a new type of immunotherapy for children and young adults with solid tumors that have not responded to standard treatments. The therapy uses the patient's own immune cells, which are genetically modified in the lab to recognize and attack cancer cells…
Matched conditions: LIVER CELL CARCINOMA
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New drug combo aims to stop liver cancer in its tracks
Disease control Recruiting nowThis phase 2 trial is testing whether adding the immunotherapy drug tislelizumab after standard liver-directed treatments (like radiation) can help control inoperable liver cancer. About 35 adults with hepatocellular carcinoma who have not had systemic therapy will receive tislel…
Matched conditions: LIVER CELL CARCINOMA
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC